K Hovnanian Childrens Hospitalto Provide Pediatric Patients Access to Cancer Treatment Trials

What you need to know

K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center has been granted Affiliate status to the Children’s Oncology Group (COG), giving K. Hovnanian Children’s Hospital patients and their families access to the latest clinical trials available to treat pediatric cancers. 

K. Hovnanian joins Joseph M. Sanzari Children’s Hospital as a COG member. 

K.  Hovnanian Children’s Hospital is among the first hospitals in the United States to be granted Affiliate status, a new designation offered by COG to allow for a second tier of member institutions. The more than 200 children’s cancer centers nationwide that comprise the Children’s Oncology Group have met the quality assurance standards established by the National Cancer Institute (NCI). 

About the Children's Oncology Group

Hackensack Meridian Children’s Health has more than 100 active oncology clinical trials. The network is also home to the only neuro-oncology lab in the state. 

It is estimated that more than 90% of the 16,000 children diagnosed with cancer each year in the United States are cared for at COG member institutions. The Children’s Oncology Group partners with research scientists from around the world in the effort to understand the causes of cancer and find more effective treatments. The Children’s Oncology Group and its predecessor organizations have had a pivotal role in transforming childhood cancer from a virtually incurable disease 50 years ago to one with a combined five-year survival rate of 80 percent today.  The collaboration with COG connects patients to the latest clinical trials and upwards of 10,000 pediatric oncology experts here in New Jersey and around the world who work with COG to develop effective new treatments for children with cancer.